stella
beta
GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma — Stella
Recruiting
Back to Primary Open-Angle Glaucoma (POAG) trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu
View full record on ClinicalTrials.gov